""" This delay will allow BOM topline to come out before Amarin gets over the final hurdles of a label expansion and approval"""

We'll hear if BOM met the significance threshold about the time of AMRN's AdCom. We won't get BOM's RRR%, though, and AMRN's Adcom should tell us a lot about what their approval/expansion prospects are.